Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anatara Lifesciences Ltd (AU:ANR)
ASX:ANR
Holding AU:ANR?
Track your performance easily
ANR Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.02 - AU$0.05
Previous CloseAU$0.05
Volume26.00K
Average Volume (3M)121.25K
Market Cap
AU$9.26M
Enterprise ValueAU$8.15M
Total Cash (Recent Filing)AU$1.17M
Total Debt (Recent Filing)AU$65.80K
Price to Earnings (P/E)―
Beta-0.04
Next Earnings
Feb 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume46,127
30 Day Avg. Volume121,246
Standard Deviation0.21
R-Squared0.07
Alpha-0.00938
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)9.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anatara Lifesciences Ltd News
PremiumCompany Announcements
Anatara Lifesciences Cuts Losses, No Dividends Paid
PremiumCompany Announcements
Anatara Issues New Employee Performance Rights
PremiumCompany Announcements
Anatara Advances IBS Trial with Strong Recruitment
PremiumCompany Announcements
Anatara Director’s Stake Changes Revealed
PremiumCompany Announcements
Anatara Lifesciences Issues New Director OptionsPremiumCompany Announcements
Anatara Lifesciences Expands Quoted Shares
PremiumCompany Announcements
Anatara Lifesciences Shareholders Approve Resolutions
PremiumCompany Announcements
Anatara Advances IBS Treatment Trial Amid Strong InterestOptions Prices
Currently, No data available
---
Ownership Overview
8.13% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.87% Public Companies and
Individual Investors
ANR FAQ
What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was AU$0.02 and its highest was AU$0.05 in the past 12 months.
What is Anatara Lifesciences Ltd’s market cap?
Currently, no data Available
When is Anatara Lifesciences Ltd’s upcoming earnings report date?
Anatara Lifesciences Ltd’s upcoming earnings report date is Feb 19, 2025 which is in 152 days.
How were Anatara Lifesciences Ltd’s earnings last quarter?
Anatara Lifesciences Ltd released its earnings results on Aug 28, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is Anatara Lifesciences Ltd overvalued?
According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued.
Does Anatara Lifesciences Ltd pay dividends?
Anatara Lifesciences Ltd does not currently pay dividends.
What is Anatara Lifesciences Ltd’s EPS estimate?
Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anatara Lifesciences Ltd have?
Anatara Lifesciences Ltd has 192,893,720 shares outstanding.
What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
Anatara Lifesciences Ltd reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20%.
Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
Currently, no hedge funds are holding shares in AU:ANR
---
Anatara Lifesciences Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ANR Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth AU$70.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.83%
12-Months-Change
Fundamentals
Return on Equity
-126.79%
Trailing 12-Months
Asset Growth
17.76%
Trailing 12-Months
Company Description
Anatara Lifesciences Ltd
Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company develops Detach, a natural, plant-based product that prevents and treats diarrhea in production animals. It generates its income from license revenue.
---
Technical Analysis
---